Clinical Trial Update: INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas [Phase 1]

View source ↗

Summary

Phase 1 trial of INCB7839 in children with recurrent or progressive high-grade gliomas has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligodendroglioma
• Cns Malignant Glioma
• Diffuse Intrinsic Pontine Glioma
• Glioblastoma
• High-grade Astrocytoma

Drugs mentioned

• INCB7839

Snippet

Sponsor: Pediatric Brain Tumor Consortium | Conditions: Glioblastoma Multiforme, Anaplastic Astrocytoma | Phase 1 | Status: COMPLETED | Results posted: 2025-02-19